New KED

   
Product New KED Eye Drops
Composition
  • Ketorolac Tromethamine 0.4%
  • HPMC 0.1%
Availability

5 ml vial FFS packing.

Therapeutic Group Non-steroidal anti-inflammatory drug (NSAID).
Mode of Action

KED inhibits the enzyme cyclo-oxygenase (COX), which is required for the synthesis of prostaglandins.

When COX is inhibited prostaglandins are not synthesized and therefore KED inhibits inflammation.

Clinical Benefits
  • Ketorolac 0.5% is as effective and well-tolerated as Prednisolone acetate 1%, while avoiding the side effects of steroids which are caused by prednisolone acetate.
  • Ketorolac tromethamine 0.5% ophthalmic solution is safe and provides substantial anti-inflammatory activity in the treatment of moderate to severe anterior segment inflammation developing after cataract surgery and intraocular lens implantation.
  • Shows significant reduction of prostaglandins in aqueous humour.
  • No significant effect on IOP.
  • Greater efficacy compared to steroids.
Adverse Effects Transient ocular burning or discomfort.

 

Yash Pharma Laboratories Pvt. Ltd. All Rights Reserved